Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Medical Bud News.
Teens and Marijuana: Navigating the New Normal of Legalization in Illinois
EIN Presswire
·
August 19, 2024
BUFFALO GROVE, ILLINOIS, UNITED STATES, August 19, 2024 /EINPresswire.com/ -- As marijuana legalization reshapes societal norms, Sandstone Care Buffalo Grove Rehab Center is tackling the rising trend of marijuana use among Illinois youth. This...
Legal Marijuana Market Projected To Witness Substantial Growth, 2024-2031: Tilray, Aphria, Inc., Wayland Group Corp
EIN Presswire
·
August 6, 2024
BURLINGAME, CALIFORNIA, UNITED STATES, August 6, 2024 /EINPresswire.com/ -- Latest Report, titled “Legal Marijuana Market” Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive...
Double Dogs Weed Dispensary Big Sky Features Montana's Premier Cannabis Brands
EIN Presswire
·
August 3, 2024
Showcasing top Montana cannabis brands, emphasizing quality and community partnerships. BIG SKY, MONTANA, UNITED STATES, August 3, 2024 /EINPresswire.com/ -- Double Dogs proudly features an extensive selection of Montana's premier cannabis...
Rank Really High and Moodi Day Revolutionize Cannabis E-Commerce with Groundbreaking User-Generated Content Integration
GlobeNewswire, Inc.
·
August 13, 2024
BOSTON, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Rank Really High, the vanguard of cannabis e-commerce innovation, announced a game-changing integration with Moodi Day, the premier video-first cannabis review platform. This strategic alliance empowers...
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million
GlobeNewswire, Inc.
·
August 16, 2024
SciSparc will receive consideration in shares, and in addition may receive cash payments and fees if certain development milestones are met TEL AVIV, Israel, Aug. 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"),...
Missouri’s Division of Cannabis Regulation announces recall for cannabis products sold by C&C Manufacturing, LLC
Missouri Department of Health and Senior Services
·
August 9, 2024
For Immediate Release Aug. 8, 2024 Media Contact: Lisa Cox Missouri Department of Health and Senior Services JEFFERSON CITY, MO – The Missouri Division of Cannabis Regulation (DCR) issued a marijuana product recall today for marijuana products...
Missouri’s Division of Cannabis Regulation announces recall for cannabis products sold by C&C Manufacturing, LLC
Missouri Department of Health and Senior Services
·
August 9, 2024
For Immediate Release Aug. 8, 2024 Media Contact: Lisa Cox Missouri Department of Health and Senior Services JEFFERSON CITY, MO – The Missouri Division of Cannabis Regulation (DCR) issued a marijuana product recall today for marijuana products...
Delta 8 Hemp - 618368 - 05/04/2022
U.S. Food and Drug Administration
·
August 10, 2024
Delivery Method: Via Email Product: Drugs Food & Beverages Recipient: Delta 8 Hemp 1116 S Main Street Los Angeles, CA 90015 United States info@delta8cart.net Issuing Office: Center for Drug Evaluation and Research | CDER United States WARNING...
Medicinal Cannabis Market Set to Witness Significant Growth by 2024-2031: Medical Marijuana Inc, Insys Therapeutics Inc
EIN Presswire
·
August 1, 2024
BURLINGAME, CALIFORNIA, UNITED STATES, August 1, 2024 /EINPresswire.com/ -- A new study titled Medicinal Cannabis Market 2024, published by the Coherent Market Insights, offers information on regional and global markets that is expected to...
Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X
GlobeNewswire, Inc.
·
July 30, 2024
IHL-42X is a fixed dose combination drug targeting obstructive sleep apnea (OSA), a medical condition with no available registered pharmaceutical treatment for millions of sufferers in the USA alone. bioavailability/bioequivalence (‘BA/BE’)...
Livewire Ergogenics Introduces “Sol Vida Spray” First-of-its-Kind Cannabis Elixir Spray
GlobeNewswire, Inc.
·
August 7, 2024
Anaheim, CA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on owning, leasing, managing, and licensing special purpose real estate properties and operations conducive to producing high-quality,...
SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug
GlobeNewswire, Inc.
·
August 6, 2024
SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by combining SciSparc’s Palmitoylethanolamide (PEA) with Clearmind’s MEAI TEL AVIV, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) --...
PAINWeek Heads to Las Vegas, September 3-6, as the Largest and Most Innovative Pain Management Conference for Frontline Healthcare Professionals
GlobeNewswire, Inc.
·
July 31, 2024
Boca Raton, FL, July 31, 2024 (GLOBE NEWSWIRE) -- Building on the momentum of a record-breaking year, PAINWeek, produced by Informa Connect, unveils details of the 18th annual conference. This year, PAINWeek tackles one of the greatest threats to...
FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed
GlobeNewswire, Inc.
·
August 5, 2024
Approval from FDA to proceed with 94 patient Phase 2 clinical trial received following review of IND dossier containing information on the clinical trial, as well as safety and quality of the investigational drug product. PsiGAD2, short for...
180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
GlobeNewswire, Inc.
·
July 30, 2024
PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced topline results from a clinical pharmacology...
Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos
GlobeNewswire, Inc.
·
July 16, 2025
Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videos Conference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring donors joined the new membership program MAPS...
THCA Flower 2025: Area 52 Unveils 2025 THCA Flower Strains – Zoap, Yaas Betch, & Lemon Cherry
GlobeNewswire, Inc.
·
June 16, 2025
Las Vegas, NV, June 16, 2025 (GLOBE NEWSWIRE) -- Area 52, the #1 online dispensary celebrated for its innovative cannabinoid formulations and unwavering dedication to quality, proudly announces the launch of its 2025 Best THCA Flower Collection....
Avicanna Announces Results of Annual General Meeting
GlobeNewswire, Inc.
·
June 30, 2025
TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived...
AI in Agriculture Market to Hit $8.97B by 2031, Driven by Robotics, Precision Farming & Analytics | DataM Intelligence
EIN Presswire
·
July 15, 2025
AI in Agriculture Market to reach US$ 8.97 billion by 2031, driven by precision farming, automation, and sustainable practices across key global regions. AUSTIN, TX, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- AI in Agriculture Market...
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
GlobeNewswire, Inc.
·
July 15, 2025
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of the...